-+ 0.00%
-+ 0.00%
-+ 0.00%

Lexeo Therapeutics to Report Third-Quarter Financial Results

PUBT·11/15/2026 12:00:13
Listen to the news
Lexeo Therapeutics to Report Third-Quarter Financial Results
  • Lexeo Therapeutics will report third-quarter 2026 financial results on Nov. 16, 2026.
  • A Nov. 16, 2026, business update will cover the HEROIC-PKP2 Phase I/II trial of LX2020 for PKP2 arrhythmogenic cardiomyopathy.
  • A webcast covering the results and business update will begin at 8 a.m. ET on Nov. 16, 2026.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Lexeo Therapeutics Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202611150700PRIMZONEFULLFEED9877723) on November 15, 2026, and is solely responsible for the information contained therein.